Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
Abstract
This study examined the importance of aldosterone (ALDO) in mediating changes in renal function and increased mean arterial pressure (MAP) during the development of dietary-induced obesity in chronically instrumented dogs. Mean arterial pressure, heart rate (HR), and cardiac output (CO) were recorded 24 hours per day in lean dogs (n=7) before and after administration of an ALDO antagonist, eplerenone (EP) (10 mg/kg twice daily), for 10 days. After 10 days of EP treatment, the dogs (n=7) were given a supplement of cooked beef fat for 5 weeks while EP was continued. An untreated group (n=6) was fed a high fat diet for 5 weeks and used as control (C). In lean dogs, EP decreased MAP from 89±4 to 84±4 mm Hg and glomerular filtration rate from 67.4±6.8 to 53.2±4.9 mL/min while inducing a small negative Na + balance (−42±12 mEq). Plasma renin activity increased from 0.4±0.1 to 2.7±0.7 ng AI/mL per hour and plasma K + increased from 4.8±0.1 to 6.1±0.3 mEq/L. After 5 weeks of a high fat diet, body weight increased 45% to 53% in EP and C obese dogs. In C dogs, MAP increased by 16±3 mm Hg, compared with only 7±1 mm Hg in EPLE dogs. Compared with untreated dogs, the EP dogs had smaller increases in CO (18±4.6% versus 43±1.5%), HR (33±5% versus 60±3%), glomerular filtration rate (19±5% versus 38±6%), and cumulative Na + balance (138±35 mEq versus 472±110 mEq) after 5 weeks of a high fat diet. Thus, EP markedly attenuated glomerular hyperfiltration, sodium retention, and hypertension associated with chronic dietary-induced obesity. These observations indicate that ALDO plays an important role in the pathogenesis of obesity hypertension.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mineralocorticoid receptor blockade markedly attenuated glomerular hyperfiltration in obese dogs fed a high-fat diet.
“We showed that MR blockade markedly attenuated glomerular hyperfiltration in obese dogs fed an HFD47.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [47]
In dogs fed a high-fat diet to produce obesity, MR antagonism with eplerenone blunted sodium retention, glomerular hyperfiltration, and the development of hypertension by more than 50%.
“In dogs fed an HFD to produce obesity, MR antagonism with eplerenone blunted sodium retention, glomerular hyperfiltration and the development of hypertension by >50%47.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [47]
In obese dogs, MR antagonism markedly attenuated sodium retention, hypertension, and glomerular hyperfiltration.
“In obese dogs, for example, MR antagonism markedly attenuated sodium retention, hypertension, and glomerular hyperfiltration51 (Figure 4).”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Experimental Design: Procedures for the Behavioral Sciences
Kirk, R. (2013) · doi:10.4135/9781483384733 · Cited by 8,539 · see citing works
New Tables for Multiple Comparisons with a Control
Dunnett, C. W. (1964) · Biometrics · doi:10.2307/2528490 · Cited by 3,105 · see citing works
Obesity Hypertension in Children
Sorof, J. M., & Daniels, S. R. (2002) · Hypertension · doi:10.1161/01.hyp.0000032940.33466.12 · Cited by 968 · see citing works
The Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868 · see citing works
Self-citationIncidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789 · see citing works
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549 · see citing works
Self-citationLong-Term Effects of Weight Loss and Dietary Sodium Reduction on Incidence of Hypertension
He, J., Whelton, P. K., Appel, L. J., Charleston, J. B., & Klag, M. J. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.544 · Cited by 430 · see citing works
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 386 · see citing works
Mechanisms of Obesity-Associated Cardiovascular and Renal Disease
Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., & Dubbert, P. M. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200209000-00003 · Cited by 373 · see citing works
Self-citationObesity-induced hypertension. Renal function and systemic hemodynamics.
Hall, J. E., Brands, M. W., Dixon, W. N., & Smith, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.22.3.292 · Cited by 328 · see citing works
Self-citationMiller, E. R., Erlinger, T. P., Young, D. R., Jehn, M., Charleston, J., Rhodes, D., Wasan, S. K., & Appel, L. J. (2002) · Hypertension · doi:10.1161/01.hyp.0000037217.96002.8e · Cited by 319 · see citing works
White, W. B., Duprez, D. A., Hillaire, R. S., Krause, S. L., Roniker, B., Kuse-Hamilton, J., & Weber, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000067463.13172.ea · Cited by 293 · see citing works
Angiotensin Blockade Prevents Type 2 Diabetes by Formation of Fat Cells
Sharma, A. M., Janke, J., Gorzelniak, K., Engeli, S., & Luft, F. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000036448.44066.53 · Cited by 283 · see citing works
Suzuki, G., Morita, H., Mishima, T., Sharov, V. G., Todor, A. V., Tanhehco, E. J., Rudolph, A. E., McMahon, E. G., Goldstein, S., & Sabbah, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000039104.56479.42 · Cited by 214 · see citing works
Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
Krum, H., Nolly, H. L., Workman, D. L., He, W., Roniker, B., Krause, S. L., & Fakouhi, K. (2002) · Hypertension · doi:10.1161/01.hyp.0000025146.19104.fe · Cited by 210 · see citing works
Pathophysiological effects of aldosterone in cardiovascular tissues
Rocha, R., & Stier, C. T. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00432-5 · Cited by 208 · see citing works
Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
Hall, J. E. (1994) · Hypertension · doi:10.1161/01.hyp.23.3.381 · Cited by 204 · see citing works
Self-citationAngiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney.
Hall, J. E., BRANDS, M., & Henegar, J. R. (1999) · PubMed · Cited by 185 · see citing works
Self-citationObesity-Induced Hypertension: New Concepts From the Emerging Biology of Obesity
Mark, A. L., Correia, M., Morgan, D. A., Shaffer, R. A., & Haynes, W. G. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.537 · Cited by 185 · see citing works
Reisin, E., Weir, M. R., Falkner, B., Hutchinson, H. G., Anzalone, D. A., & Hypertension, M. L. T. F. T. T. I. O. P. W. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.140 · Cited by 158 · see citing works
Role of renal hemodynamics and arterial pressure in aldosterone "escape".
Hall, J. E., Granger, J. P., Smith, M. J., & Premen, A. J. (1984) · Hypertension · doi:10.1161/01.hyp.6.2_pt_2.i183 · Cited by 153 · see citing works
Self-citationCardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading
Martinez-Vasquez, D., Rocha, R., Matsumura, M., Oestreicher, E. M., Ochoa-Maya, M. R., Roubsanthisuk, W., Williams, G. H., & Adler, G. K. (2002) · Hypertension · doi:10.1161/hyp.39.2.614 · Cited by 134 · see citing works
Clonidine Prevents Insulin Resistance and Hypertension in Obese Dogs
Rocchini, A. P., Mao, H. Z., Babu, K., Marker, P. H., & Rocchini, A. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.548 · Cited by 98 · see citing works
Altered Renal Handling of Sodium in Human Hypertension
Strazzullo, P., Galletti, F., & Barba, G. (2003) · Hypertension · doi:10.1161/01.hyp.0000066844.63035.3a · Cited by 98 · see citing works
Papassotiropoulos, A., Bagli, M., Jessen, F., Rao, M. L., Schwab, S. G., & Heun, R. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017129 · Cited by 67 · see citing works
Tubuloglomerular feedback in rat kidneys of different renin contents
Müller-Suur, R., Gutsche, H. U., Samwer, K. F., Oelkers, W., & Hierholzer, K. (1975) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00581276 · Cited by 57 · see citing works
Abnormal pressure natriuresis in the dog model of obesity-induced hypertension.
Granger, J. P., West, D., & Scott, J. (1994) · Hypertension · doi:10.1161/01.hyp.23.1_suppl.i8 · Cited by 56 · see citing works
Rahmouni, K., Barthelmebs, M., Grima, M., et al. (2001) · Hypertension · doi:10.1161/hy1001.091781 · Cited by 52 · see citing works
Arterial baroreceptor reflex function in borderline hypertensive rats.
DiBona, G. F., & Jones, S. Y. (1992) · Hypertension · doi:10.1161/01.hyp.19.1.56 · Cited by 46 · see citing works
Cardiovascular regulation in obesity-induced hypertension.
Rocchini, A. P. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i56 · Cited by 46 · see citing works
Analysis of Long-Term Potassium Regulation*
Young, D. B. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-24 · Cited by 42 · see citing works
Robles, R. G., Villa, E., Santirso, R., Martinez, J., Ruilope, L. M., Carmen, C., & Sancho, J. M. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.12.1009 · Cited by 42 · see citing works
Mineralocorticoid and Angiotensin Receptor Antagonism During Hyperaldosteronemia
Mihailidou, A. S., Mardini, M., Funder, J. W., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000025904.23047.27 · Cited by 19 · see citing works
Hypertension in postmenopausal women
Barrett-Connor, E. L. (1996) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00131-2 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Miller ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT) Hypertension. 2002;40:612-618.
- Reisen E, Weir M, Falkner B. Hutchinson HG, Anzalone DA, Tuck ML. Lisinopril versus hydrochlorothiazide in obese hypertensive patients. Hypertension. 1997;30:140 -145.
- Hall JE. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994;23:381-394.
- Hall JE, Guyton AC, Farr BM. A single-injection technique for measuring glomerular filtration rate. Am J Physiol. 1977;232:F72-F76.
Cited by
Sorted by citations
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360 · see citing works
Self-citationGlomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887 · see citing works
Glomerular hyperfiltration: definitions, mechanisms and clinical implications
Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.19 · Cited by 673 · see citing works
Brown, S., Atkins, C., Bagley, R., Carr, A., Cowgill, L., Davidson, M., Egner, B., Elliott, J., Henik, R., Labato, M., et al. (2007) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2007.tb03005.x · Cited by 748 · see citing works
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654 · see citing works
Self-citationObesity, hypertension, and chronic kidney disease
Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520 · see citing works
Self-citationHypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232 · see citing works
Self-citationObesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis
Rahmouni, K. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.00920 · Cited by 150 · see citing works
Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic Syndrome
Fujita, T. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149062 · Cited by 130 · see citing works
Mechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems
Fujita, T. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121258 · Cited by 124 · see citing works
Impact of Leptin-Mediated Sympatho-Activation on Cardiovascular Function in Obese Mice
Belin de Chantemèle, E. J., Mintz, J. D., Rainey, W. E., & Stepp, D. W. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168427 · Cited by 103 · see citing works
Body Mass Index and Angiotensin-Dependent Control of the Renal Circulation in Healthy Humans
Ahmed, S. B., Fisher, N. D. L., Stevanovic, R., & Hollenberg, N. K. (2005) · Hypertension · doi:10.1161/01.hyp.0000190819.07663.da · Cited by 92 · see citing works
Morbid Obesity, Hypertensive Disease and the Renin-Angiotensin-Aldosterone Axis
Ruano, M., Silvestre, V, Castro, R., García-Lescún, M. C. G., Rodríguez, A., Marco, A., & García-Blanch, G. (2005) · Obesity Surgery · doi:10.1381/0960892053923734 · Cited by 83 · see citing works
Aldosterone Blunts Tubuloglomerular Feedback by Activating Macula Densa Mineralocorticoid Receptors
Fu, Y., Hall, J. E., Lu, D., Lin, L., Manning, R. D., Cheng, L., Gomez-Sanchez, C. E., Juncos, L. A., & Liu, R. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.173195 · Cited by 65 · see citing works
Self-citationFat tissue metabolism and adrenal steroid secretion
Lamounier-Zepter, V., & Ehrhart-Bornstein, M. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0038-3 · Cited by 34 · see citing works
de Chantemèle, E. J. B., Ali, M. I., Mintz, J. D., Rainey, W. E., Tremblay, M. L., Fulton, D. J., & Stepp, D. W. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196295 · Cited by 25 · see citing works
- Authors
- de Paula, R. B., da Silva, A. A., & Hall, J. E.
- Affiliations
- From the Department of Physiology and Biophysics and Center of Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson.
- University of Mississippi Medical Center (US)
- ORCID
- Hall, John E.
- Venue
- Hypertension
- Published
- 2004-01
- Volume
- 43
- Issue
- 1
- Pages
- 41-47
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2097090923
- Cited by
- 207
- References
- 34
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 12 · 2014: 8 · 2013: 11 · 2012: 19
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01-HL-51971, P01HL051971)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- aldosterone, eplerenone, obesity-related hypertension, glomerular hyperfiltration, diet-induced obesity, high-fat diet, sodium retention, plasma renin activity, plasma potassium, cardiac output, heart rate, renal function, mineralocorticoid receptor antagonists
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Animals, Dogs, Glomerular Filtration Rate, Hemodynamics, Hormones, Hypertension, Obesity, Sodium, Spironolactone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review